Effects of several virucidal agents on inactivation of influenza, Newcastle disease, and avian infectious bronchitis viruses in the allantoic fluid of chicken eggs

Japanese Journal of Infectious Diseases

Volumn 60, Issue 6, 2007, Pages 342-346

  Abe, Motoharu ^a   Kaneko, Kumi ^a   Ueda, Ai ^a   Otsuka, Hiroshi ^a   Shiosaki, Kouichi ^a   Nozaki, Chikateru ^a   Goto, Shuro ^a  

^a Kaketsuken   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZALKONIUM CHLORIDE; HYPOCHLORITE SODIUM; SODIUM HYDROXIDE; VIRUS VACCINE;

ACTIVATED SLUDGE; AMNION FLUID; ANTIVIRAL ACTIVITY; ARTICLE; AVIAN INFECTIOUS BRONCHITIS VIRUS; BIODEGRADABILITY; CHICKEN; CONCENTRATION RESPONSE; CONTROLLED STUDY; EGG; INCUBATION TIME; INFLUENZA VIRUS; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; QUANTITATIVE ANALYSIS; VACCINE PRODUCTION; VIRUS INACTIVATION; VIRUS STRAIN;

ALLANTOIS; ANIMALS; ANTI-INFECTIVE AGENTS; BENZALKONIUM COMPOUNDS; CHICK EMBRYO; ETHANOL; INFECTIOUS BRONCHITIS VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA B VIRUS; NEWCASTLE DISEASE VIRUS; ORTHOMYXOVIRIDAE; SODIUM HYDROXIDE; SODIUM HYPOCHLORITE; VIRUS INACTIVATION;

EID: 36549066642     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Oxford, J.S., Potter, C.W., McLaren, C., et al. (1971): Inactivation of influenza and other viruses by a mixture of virucidal compounds. Appl. Microbiol., 21, 606-610.
2. Ono, T. (1986): (Detergents). Med. Drug J., 22, 33-37 (text in Japanese).
3. Iwashige, K., Ina, H., Masaki, H., et al. (1987): (Selection and usage of sterilizing antiseptics). Med. Drug J., 23, 373-381 (text in Japanese).
4. Spaulding, E.H. and Groschel, D.H.M. (1974): Infection Prevention: Hospital Disinfectant and Antiseptics. p. 852-857. In Manual of Clinical Microbiology. 2nd ed.
5. Pike, D.G., Peabody, J.W., Davis, E.W., et al. (1963): A re-evaluation of the dangers of clorox ingestion. J. Pediatr., 63, 303-305.
6. Weeks, R.S. and Ravitch, M.M. (1969): Esophageal injury by liquid chlorine bleach: experimental study. J. Pediatr., 74, 911-916.
7. Kawana, R., Kitamum, T., Nakagomi, O., et al. (1997): Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology, 195, Suppl. 2, 29-35.
8. World Health Organization (1998): Recommended composition of influenza virus vaccines for use in the 1998 - 1999 season. Wkly. Epidemiol. Rec., 73, 56-63.
9. Hiromoto, Y, Saito, T, Lindstrom, S.E., et al. (2000): Phylogenetic analysis of the three polymerase genes (PB1, PB2 and PA) of influenza B virus. J. Gen. Virol., 81, 929-937.
10. Wood, J.M. and Robertson, J.S. (2004): From lethal virus to life-saving vaccine: developing inactivated vaccines for pandernic influenza. Nat. Rev. Microbiol., 2, 842-947.
11. Deguchi, K., Honda, T., Matsuo, K., et al. (1998): Influence of inoculation site of combined oil-adjuvanted vaccine on the antibody response in chickens. J. Vet. Med. Sci., 60, 831-835.
12. National Institute of Infectious Diseases (2006): Influenza HA Vaccine. p. 17-21. Minimum Requirements for Biological Products, 2006. Online at .
13. Office of the Federal Register National Archives and Records Administration (2001): Animals and animal products. 9 CFR, Standard requirements. part 113, p. 552-682.
14. Versteeg, J. (1985): Chick embryo techniques. p. 38-66. In Versteeg, J. (ed.), A Colour Atlas of Virology. Wolfe Medical Publications, Netherlands.
15. al-Tarcha, B., Kojnok, J. and Varro, C. (1990): Isolation and characterization of new infectious bronchitis virus variants in Hungary. Acta Vet. Hung., 38, 287-298.
16. World Health Organization (2005): WHO Expert Committee on biological standardization. Fifty-four report. WHO Tech. Rep. Ser., 927, 99-134.
17. Fujimoto, S. (1977): (Sterilization). Clin. Virol., 5, 29-32 (text in Japanese).
18. Shimada, S. (1991): (Regarding antiseptics). Jpn. J. Clin. Exp. Med., 68, 63-69 (text in Japanese).
19. Tomonaga, H. (1986): (Classification and characteristics of antiseptics). Med. Drug J., 22, 24-28 (text in Japanese).
20. Alfredson, B.V., Stiefel, J.R., Thorp, F., Jr., et al. (1951): Toxicity studies on alkydimethyl-benzylammonium chloride in rats and in dogs. J. Am. Pharm. Assoc., 40, 263-267.
21. Coulston, F., Drobeck, H.P., Mielens, Z.E., et al. (1961): Toxicology of benzalkonium chloride given orally in milk or water to rats and dogs. Toxicol. Appl. Pharmacol., 3, 584-594.
22. Lovell, C.R. and Staniforth, P. (1981): Contact allergy to benzalkonium chloride in plaster of Paris. Contact Dermatitis, 7, 343-344.
23. Sakagami, Y., Yokoyama, H. and Ose Y. (1982): Degradiation of organochlorine compounds in the river sludge. J. Antibact. Antifung. Agents, 10, 61-69.
24. Yokoyama, H. and Sakagami, Y. (1984): Degradiation and acclimatization of some disinfectants by bacteria isolated from river-sludge. J. Antibact. Antifung. Agents, 12, 219-226.
25. Association of Biologicals Manufactures of Japan (1986): Japanese encephalitis vaccine. p. 98-102. Minimum Requirements for Biological Products, 1986.
26. Abe, M., Shiosaki, K, Hammar, L., et al. (2006): Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines. Virus Res., 121, 152-160.
27. Halperin, SA., Smith, B., Mabrouk, T., et al. (2002): Safely and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children. Vaccine, 20, 1240-1247.
28. Kuzuhara, S., Nakamura, H., Hayashida, K., et al. (2003): Non-clinical and phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine. Vaccine, 21, 4519-4526.
29. Sugawara, K., Nishiyama, K., Ishikawa, Y., et al. (2002): Development of Vero cell-derived inactivated Japanese encephalitis vaccine. Biologicals, 30, 303-314.